Facts
as of Nov 21, 2026
Teleflex is a medical technology company that designs and manufactures single-use devices for critical care, surgery, interventional and urology procedures, under brands such as Arrow, LMA, Rusch, UroLift and Weck. Founded in 1943 and listed on the New York Stock Exchange, it sells to hospitals and healthcare providers in about 150 countries and runs manufacturing and R&D sites in the US, Ireland, the Czech Republic, Mexico and Malaysia. The company is headquartered in Wayne, Pennsylvania, United States.
It is hiring: 137 open roles, 63 of them posted in the last 30 days. Its stated pay is 24% above the market estimate for the same roles.
- Legal name
- TELEFLEX INC
- Headquarters
- Wayne, United States
- Founded
- 1943
- Employees
- 3,643US Form 5500 (plan participants) · Dec 2025 · -5% in a year
- Subsidiaries
- 139 in 47 countriesUnited States 31, Ireland 12, Cyprus 6, Netherlands 6 · SEC 10-K Exhibit 21
- Listing
- NYSE: TFX
- Register numbers
- EIN 231147939
As of Nov 21, 2026, Alion lists 137 open roles at Teleflex. Teleflex is headquartered in Wayne, United States. It was founded in 1943. The median pay stated in its open roles is $120k, across 31 postings that state pay.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Teleflex has $2.1M paid in by investors, lenders and donors.
$2.1MPaid in
$2.1MDonations received
$117.7MIncome taxes paidFY2025
$360.3MDividends and buybacksFY2025
Money innewest first
Donation · Donors
Jan 2023 · Contributions and grants received
$1.1MPaid
Donation · Donors
Jan 2021 · Contributions and grants received
$1MPaid
Revenue by yearas filed, with the net income
2025$2Bnet income −$905.6M
2024$1.7Bnet income $69.7M
2023$1.7Bnet income $356.3M
2022$2.8Bnet income $363.1M
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Teleflex operates through 8 legal entities in 5 countries.
Legal entities8 in 5 countries
TELEFLEX INC
operator · US EIN 231147939
US
subsidiary · SG UEN 201529707D
SG
subsidiary · IE CRO 428329
IE
Teleflex Medical Inc.
subsidiary · US EIN 951867330
US
Stakes and purchases
ownership of shares 50 to 75 percent; voting rights 50 to 75 percent; right to appoint and remove directors
50%
Holders and shares as each register or filing states them.
137 open roles, 63 of them posted in the last 30 days. Its stated pay is 24% above the market estimate for the same roles.
137Open roles63 posted in 30 days
$120kMedian advertised pay$65k – $140k+24% vs market
28 daysTime to fillmarket: 34 days
3,643EmployeesUS Form 5500 (plan participants) · Dec 2025 · -5% in a year
Head countas filed and stated
Where the openings areshare of open roles
Sales23%
Field & Service17%
Engineering17%▼
Operations8%
Administrative8%▲
Open roles over time−100%
Sep 28This week
Open roles a week: 121 then, 0 now
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Teleflex has 16 clinical trials on record, 5 under way. It holds 9 FDA 510(k) clearances. Teleflex paid US doctors and teaching hospitals $7.8M in 2025, and $948k for research (CMS Open Payments).
Clinical trials
Safety And Field Evaluation of Plasma Lyophilized for Acute and Surgical Management Applications
phase 4 · under way · 867 participants · Thromboembolic Event; FDP
Oct 2027
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary A…
under way · 1,859 participants · Coronary Disease; Heart Diseases; Cardiovascular Diseases; Arteriosclerosis
Jun 2026
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary …
under way · 150 participants · Coronary Artery Disease
Jul 2025
Biggest buyers332 · $96.9M
GIP RESAH
France · 7 public contracts
$16.2M
Uniwersytecki Szpital Kliniczny nr 4 w Lublinie
Poland · 9 public contracts
$15.1M
CHU de Toulouse
France · 4 public contracts
$14.2M
Wikipedia readersen.wikipedia.org
Nov 2024Oct 2026 · 729
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Teleflex: an SBTi-validated climate target, 23 research papers in five years, 1 notable 8-K reports, 1 competition cases, $250k of EU lobbying in 2025, 10 federal court cases.
Legal entity active
TELEFLEX INC
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Domain and mail security
teleflex.com · Nov 15, 2026
2 of 8 pass
Court cases
Oct 2017 – Dec 2025 · 10 as defendant · 9 closed
10
FDA recalls
387 products since 2012 · 180 of class I
106
US lobbying
2025 · Arnold & Porter Kaye Scholer LLP $160,000, Cornerstone Government Affairs, Inc. $90,000
$250k
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Newsroom
NewsTeleflex stock gains clinical support from a 70 percent study finding
Oct 8
Press releasepalmbeachpost.com
Oct 7
Sources: the outlets named on each headline, each story once
Ranked #6 by open roles among its 11 closest peers.
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)